We are live on ! Find out more
JP Morgan Chase

JP Morgan Chase Portfolio holdings

AUM $1.81T
1-Year Est. Return 41.13%
 

JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.

This Fund
S&P 500
This Quarter Est. Return
+9.21%
1 Year Est. Return
+41.13%
3 Year Est. Return
+122.17%
5 Year Est. Return
+152.24%
10 Year Est. Return
+601.59%
AUM
$866B
AUM Growth
+$57.2B
Cap. Flow
-$1.57B
Cap. Flow %
-0.18%
Top 10 Hldgs %
16.98%
Holding
7,322
New
665
Increased
2,967
Reduced
2,175
Closed
543

Sector Composition

Rank Sector Weight
1 Technology 16.74%
2 Financials 10.42%
3 Healthcare 9.81%
4 Consumer Discretionary 9.59%
5 Industrials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INDI icon
5276
indie Semiconductor
INDI
$875M
$158K ﹤0.01%
+13,181
New +$167K
SBS icon
5277
Sabesp
SBS
$17.9B
$158K ﹤0.01%
111,360
+242
+0.2% +$314
SEEL
5278
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$158K ﹤0.01%
25
+15
+150% +$115K
SKIL.WS
5279
DELISTED
Skillsoft Corp. Warrants, each whole warrant is exercisable for 1/20th of a share of Class A Common Stock at an exercise price of $230.00
SKIL.WS
0
CLAS
5280
DELISTED
Class Acceleration Corp.
CLAS
$158K ﹤0.01%
16,222
SLN
5281
Silence Therapeutics
SLN
$660M
$157K ﹤0.01%
+6,730
New +$156K
SUP
5282
DELISTED
Superior Industries International
SUP
$156K ﹤0.01%
34,737
+2,799
+9% +$14.8K
ALBO
5283
DELISTED
Albireo Pharma Inc
ALBO
$156K ﹤0.01%
6,669
+302
+5% +$8.03K
NKTR icon
5284
CALL
Nektar Therapeutics
NKTR
$2.57B
$155K ﹤0.01%
+767
New +$166K
ATCX
5285
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$155K ﹤0.01%
18,311
+8,220
+81% +$78.9K
REV
5286
DELISTED
Revlon, Inc.
REV
$155K ﹤0.01%
13,632
+8,049
+144% +$93.4K
SH icon
5287
ProShares Short S&P500
SH
$839M
$154K ﹤0.01%
2,830
+1,005
+55% +$57.1K
CLBT icon
5288
Cellebrite
CLBT
$2.69B
$153K ﹤0.01%
19,089
+5,664
+42% +$53.4K
GCMGW
5289
DELISTED
GCM Grosvenor Inc Warrant
GCMGW
0
PL icon
5290
Planet Labs
PL
$8.82B
$153K ﹤0.01%
+24,807
New +$235K
PLTR icon
5291
CALL
Palantir
PLTR
$430B
$153K ﹤0.01%
8,400
-447,800
-98% -$9.89M
VIXM icon
5292
ProShares VIX Mid-Term Futures ETF
VIXM
$94.4M
$153K ﹤0.01%
5,015
-1,659
-25% -$51.5K
CLVS
5293
DELISTED
Clovis Oncology, Inc.
CLVS
$153K ﹤0.01%
56,359
+4,913
+10% +$18.2K
JHMM icon
5294
John Hancock Multifactor Mid Cap ETF
JHMM
$6.18B
$152K ﹤0.01%
2,733
SDS icon
5295
ProShares UltraShort S&P500
SDS
$365M
$151K ﹤0.01%
856
+362
+73% +$69.6K
CUE icon
5296
PUT
Cue Biopharma
CUE
$128M
$149K ﹤0.01%
+440
New +$170K
INNV icon
5297
InnovAge Holding
INNV
$1.42B
$149K ﹤0.01%
29,814
+14,808
+99% +$108K
TEAD
5298
Teads Holding Co
TEAD
$64.4M
$149K ﹤0.01%
10,645
+4,814
+83% +$74.1K
WKHS icon
5299
CALL
Workhorse Group
WKHS
$33.7M
$149K ﹤0.01%
11
XENE icon
5300
Xenon Pharmaceuticals
XENE
$6.31B
$149K ﹤0.01%
4,775
+1,761
+58% +$52.6K

Similar funds

JP Morgan Chase's Q4 2021 Portfolio in Review

As of Q4 2021, JP Morgan Chase held 7,322 positions worth $866B, up 7.1% from $809B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

JP Morgan Chase's Q4 2021 filing shows 665 new, 2,967 increased, 2,175 reduced and 543 closed positions. Its largest new stake was Rivian: 4,642,731 shares worth $481M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $4.32B.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • JP Morgan Chase's largest Q4 2021 buy was Rivian: 4,642,731 shares worth $481M.
  • JP Morgan Chase added most to Amazon in Q4 2021, an estimated $2.21B increase.
  • JP Morgan Chase's biggest Q4 2021 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $4.32B.
  • JP Morgan Chase fully exited Kansas City Southern in Q4 2021, selling an estimated $499M.
  • JP Morgan Chase's ten largest holdings make up 17% of its $866B portfolio in Q4 2021.
  • JP Morgan Chase opened 665 new positions and closed 543 in Q4 2021.
  • JP Morgan Chase's portfolio value rose 7.1% quarter-over-quarter to $866B.

Based on JP Morgan Chase's 13F filing for Q4 2021, filed 10 Feb 2022.